Announcement
27 Aug 2020
In August 2020, the European Union signed an Advanced Purchase Agreement (APA) with AstraZeneca with respect to the European doses of the company’s COVID-19 vaccines. The agreement was published in January 2021.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
27 Aug 2020
Revocation date:
No revocation date
Updated: 27 Aug 2020
Local operations incentive
In force
On 27 August 2020, the EU and AstraZeneca signed an Advanced Purchase Agreement (APA) for the production, purchase and supply of the company’s COVID-19 vaccine. However, it was not until 29 January...
Sign in to see more
Related State Acts
29 Jan 2021
EU: Commission adopts temporary export authorisation for COVID-19 vaccines
30 Nov 2020
EU: COVID-19 Advanced Purchase Agreement with CureVac includes localisation requirement
20 Nov 2020
EU: Localisation requirement included in the Advanced Purchase Agreement with BioNTech-Pfizer
18 Sep 2020
EU: Advanced Purchase Agreement with Sanofi-GSK includes localisation incentive
Threads
See all
This state act is not part of any Thread yet.